Envestnet Asset Management Inc. Has $223.07 Million Stake in CME Group Inc. $CME

Envestnet Asset Management Inc. increased its stake in CME Group Inc. (NASDAQ:CME) by 41.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 825,614 shares of the financial services provider’s stock after purchasing an additional 240,799 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.23% of CME Group worth $223,073,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the stock. Amundi increased its holdings in CME Group by 24.0% in the 2nd quarter. Amundi now owns 1,987,347 shares of the financial services provider’s stock valued at $548,150,000 after buying an additional 385,225 shares during the period. Truist Financial Corp boosted its position in shares of CME Group by 8.9% during the 3rd quarter. Truist Financial Corp now owns 70,712 shares of the financial services provider’s stock valued at $19,106,000 after acquiring an additional 5,773 shares in the last quarter. Alley Investment Management Company LLC boosted its position in shares of CME Group by 86.0% during the 3rd quarter. Alley Investment Management Company LLC now owns 29,223 shares of the financial services provider’s stock valued at $7,896,000 after acquiring an additional 13,512 shares in the last quarter. Elevate Capital Advisors LLC increased its stake in CME Group by 85.2% in the third quarter. Elevate Capital Advisors LLC now owns 8,519 shares of the financial services provider’s stock valued at $2,302,000 after acquiring an additional 3,919 shares during the period. Finally, Victory Financial Group LLC raised its position in CME Group by 310.2% in the second quarter. Victory Financial Group LLC now owns 3,044 shares of the financial services provider’s stock worth $839,000 after purchasing an additional 2,302 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on CME shares. The Goldman Sachs Group lowered their price objective on CME Group from $265.00 to $264.00 and set a “sell” rating on the stock in a research note on Wednesday, January 14th. UBS Group reaffirmed a “neutral” rating on shares of CME Group in a research note on Tuesday, January 6th. Deutsche Bank Aktiengesellschaft increased their price objective on CME Group from $310.00 to $318.00 and gave the stock a “buy” rating in a research note on Wednesday, December 17th. Bank of America boosted their target price on shares of CME Group from $201.00 to $209.00 in a research note on Wednesday, December 10th. Finally, Piper Sandler upped their target price on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $295.82.

CME Group Price Performance

Shares of CME stock opened at $297.38 on Friday. CME Group Inc. has a 52 week low of $239.70 and a 52 week high of $302.20. The stock has a market capitalization of $107.24 billion, a PE ratio of 26.65, a PEG ratio of 3.32 and a beta of 0.27. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.03. The stock’s fifty day moving average is $276.48 and its 200-day moving average is $272.84.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the business posted $2.52 earnings per share. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. Equities research analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director William R. Shepard acquired 251 shares of CME Group stock in a transaction on Tuesday, December 30th. The shares were purchased at an average price of $278.37 per share, with a total value of $69,870.87. Following the acquisition, the director owned 258,710 shares in the company, valued at $72,017,102.70. This represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Terrence A. Duffy sold 25,000 shares of the stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the completion of the transaction, the chief executive officer owned 65,804 shares in the company, valued at $17,737,468.20. The trade was a 27.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is currently owned by corporate insiders.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Q4 results and record annual figures: CME posted Q4 EPS of $2.77 and revenue of ~$1.65B, with record 2025 annual revenue of $6.5B and all-time-high average daily volume in Q4 — fundamental beat that supports revenue resilience and margin strength. CME Group Q4 Earnings and Revenues Top Estimates, ADV Rises Y/Y
• Positive Sentiment: Management guidance and strategy: Management said fee adjustments could lift revenue ~1%–1.5% and reiterated plans to expand 24/7 crypto and securities clearing — a structural growth lever if adoption ramps. CME targets 1%-1.5% revenue lift; expanding 24/7 crypto
• Positive Sentiment: Morgan Stanley maintains Buy: A Wall Street analyst reiterated a Buy / Overweight view citing CME’s resilient fee-based franchise and underappreciated structural growth, supporting medium‑term upside. Morgan Stanley maintains Buy
• Neutral Sentiment: RBC raises price target modestly to $302 (sector perform): a small lift in analyst valuation but not a clear catalyst given the modest upside. RBC raises PT to $302
• Neutral Sentiment: Raymond James trims price target slightly to $310 but keeps Outperform — minimal change to the investment thesis. Raymond James adjusts PT to $310
• Neutral Sentiment: CEO says firm is exploring a proprietary token and tokenized cash pilots (with Google) to enable faster collateral movement and potential 24/7 trading — strategically important but execution, regulatory and adoption risks leave near-term impact uncertain. CME exploring issuing token
• Negative Sentiment: JPMorgan keeps an Underweight rating and has a $266 target (below current levels), signaling downside risk if volumes or product adoption slow relative to expectations. JPMorgan maintains Underweight, PT $266
• Negative Sentiment: Analyst caution / valuation note: a Seeking Alpha piece argues quality doesn’t automatically justify a buy today — a reminder that valuation and long-term growth execution should be assessed before adding exposure. CME Group: Quality Shines Through, But It Doesn’t Mean To Buy

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.